Back to Search
Start Over
Halucenex Life Sciences targets Australian market following TGA decision
- Source :
- Cannabis Industry Insight. February 9, 2023
- Publication Year :
- 2023
-
Abstract
- CANNABIS INDUSTRY INSIGHT-(C)2023 M2 COMMUNICATIONS Creso Pharma Limited (ASX:CPH, FRA:1X8) has said that its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc., is looking at opportunities to register its synthetic psilocybin [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Cannabis Industry Insight
- Publication Type :
- Periodical
- Accession number :
- edsgcl.736344072